ZJYL Fundamental Analysis - JIN MEDICAL INTERNATIONAL LT

Fundamental Rating

ZJYL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of ZJYL get a neutral evaluation. Nothing too spectacular is happening here. ZJYL has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

ZJYL had positive earnings in the past year.

In the past year ZJYL had a positive cash flow from operations.

In the past 5 years ZJYL has always been profitable.

Of the past 5 years ZJYL 4 years had a positive operating cash flow.

1.2 Ratios

ZJYL has a better Return On Assets (3.69%) than 79.47% of its industry peers.

ZJYL has a better Return On Equity (6.42%) than 79.47% of its industry peers.

Looking at the Return On Invested Capital, with a value of 3.84%, ZJYL is in the better half of the industry, outperforming 72.63% of the companies in the same industry.

Measured over the past 3 years, the Average Return On Invested Capital for ZJYL is in line with the industry average of 8.88%.

The last Return On Invested Capital (3.84%) for ZJYL is well below the 3 year average (9.49%), which needs to be investigated, but indicates that ZJYL had better years and this may not be a problem.

		Industry Rank	Sector Rank
ROA	3.69%
ROE	6.42%
ROIC	3.84%

ROA(3y)9.9%

ROA(5y)10.46%

ROE(3y)14.18%

ROE(5y)16.34%

ROIC(3y)9.49%

ROIC(5y)11.9%

1.3 Margins

ZJYL has a better Profit Margin (7.85%) than 80.00% of its industry peers.

ZJYL's Profit Margin has declined in the last couple of years.

ZJYL has a Operating Margin of 8.57%. This is in the better half of the industry: ZJYL outperforms 76.84% of its industry peers.

In the last couple of years the Operating Margin of ZJYL has declined.

ZJYL has a Gross Margin of 35.79%. This is in the lower half of the industry: ZJYL underperforms 71.58% of its industry peers.

ZJYL's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	8.57%
PM (TTM)	7.85%
GM	35.79%

OM growth 3Y6.9%

OM growth 5Y-6.46%

PM growth 3Y7.26%

PM growth 5Y-2.67%

GM growth 3Y9.69%

GM growth 5Y1.86%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ZJYL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.

ZJYL has more shares outstanding than it did 1 year ago.

ZJYL has less shares outstanding than it did 5 years ago.

Compared to 1 year ago, ZJYL has a worse debt to assets ratio.

2.2 Solvency

ZJYL has an Altman-Z score of 3.39. This indicates that ZJYL is financially healthy and has little risk of bankruptcy at the moment.

ZJYL has a better Altman-Z score (3.39) than 68.95% of its industry peers.

A Debt/Equity ratio of 0.56 indicates that ZJYL is somewhat dependend on debt financing.

ZJYL has a Debt to Equity ratio of 0.56. This is in the lower half of the industry: ZJYL underperforms 63.16% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.56
Debt/FCF	N/A
Altman-Z	3.39

ROIC/WACC0.55

WACC6.93%

2.3 Liquidity

ZJYL has a Current Ratio of 2.11. This indicates that ZJYL is financially healthy and has no problem in meeting its short term obligations.

ZJYL has a worse Current ratio (2.11) than 61.58% of its industry peers.

A Quick Ratio of 1.90 indicates that ZJYL should not have too much problems paying its short term obligations.

ZJYL has a Quick ratio (1.90) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	2.11
Quick Ratio	1.9

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ZJYL have decreased strongly by -39.04% in the last year.

Measured over the past 5 years, ZJYL shows a small growth in Earnings Per Share. The EPS has been growing by 3.28% on average per year.

ZJYL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.42%.

The Revenue has been growing slightly by 2.90% on average over the past years.

EPS 1Y (TTM)-39.04%

EPS 3Y5.52%

EPS 5Y3.28%

EPS Q2Q%-105.22%

Revenue 1Y (TTM)13.42%

Revenue growth 3Y4.22%

Revenue growth 5Y2.9%

Sales Q2Q%-6.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 34.48 indicates a quite expensive valuation of ZJYL.

ZJYL's Price/Earnings ratio is a bit cheaper when compared to the industry. ZJYL is cheaper than 71.58% of the companies in the same industry.

ZJYL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.67.

		Industry Rank	Sector Rank
PE	34.48
Fwd PE	N/A

4.2 Price Multiples

99.47% of the companies in the same industry are more expensive than ZJYL, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	1.45

4.3 Compensation for Growth

ZJYL has a very decent profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)10.52

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ZJYL!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

JIN MEDICAL INTERNATIONAL LT

NASDAQ:ZJYL (10/23/2025, 8:00:02 PM)

After market: 0.3327 -0.01 (-3.51%)

0.3448

+0 (+1%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.45%

Inst Owner Change0%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap53.98M

Revenue(TTM)22.83M

Net Income(TTM)1.79M

AnalystsN/A

Price TargetN/A

Short Float %0.3%

Short Ratio0.4

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	34.48
Fwd PE	N/A
P/S	2.36
P/FCF	N/A
P/OCF	41.37
P/B	1.93
P/tB	2.01
EV/EBITDA	1.45

EPS(TTM)0.01

EY2.9%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.01

FCFYN/A

OCF(TTM)0.01

OCFY2.42%

SpS0.15

BVpS0.18

TBVpS0.17

PEG (NY)N/A

PEG (5Y)10.52

Graham Number0.2

Profitability

		Industry Rank	Sector Rank
ROA	3.69%
ROE	6.42%
ROCE	7.04%
ROIC	3.84%
ROICexc	13.32%
ROICexgc	14.59%
OM	8.57%
PM (TTM)	7.85%
GM	35.79%
FCFM	N/A

ROA(3y)9.9%

ROA(5y)10.46%

ROE(3y)14.18%

ROE(5y)16.34%

ROIC(3y)9.49%

ROIC(5y)11.9%

ROICexc(3y)22.47%

ROICexc(5y)22.7%

ROICexgc(3y)23.46%

ROICexgc(5y)23.49%

ROCE(3y)12.88%

ROCE(5y)15.84%

ROICexgc growth 3Y-2.39%

ROICexgc growth 5Y-7.19%

ROICexc growth 3Y-4.58%

ROICexc growth 5Y-8.54%

OM growth 3Y6.9%

OM growth 5Y-6.46%

PM growth 3Y7.26%

PM growth 5Y-2.67%

GM growth 3Y9.69%

GM growth 5Y1.86%

F-Score4

Asset Turnover0.47

Health

		Industry Rank	Sector Rank
Debt/Equity	0.56
Debt/FCF	N/A
Debt/EBITDA	7.13
Cap/Depr	847.75%
Cap/Sales	9.25%
Interest Coverage	5.51
Cash Conversion	59.19%
Profit Quality	N/A
Current Ratio	2.11
Quick Ratio	1.9
Altman-Z	3.39

F-Score4

WACC6.93%

ROIC/WACC0.55

Cap/Depr(3y)178.09%

Cap/Depr(5y)117.95%

Cap/Sales(3y)1.86%

Cap/Sales(5y)1.33%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-39.04%

EPS 3Y5.52%

EPS 5Y3.28%

EPS Q2Q%-105.22%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)13.42%

Revenue growth 3Y4.22%

Revenue growth 5Y2.9%

Sales Q2Q%-6.4%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-15.9%

EBIT growth 3Y11.4%

EBIT growth 5Y-3.75%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-118.58%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-70.18%

OCF growth 3YN/A

OCF growth 5YN/A

JIN MEDICAL INTERNATIONAL LT (ZJYL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens